Literature DB >> 169244

Interaction of the estradiol receptor from calf uterus with its nuclear acceptor sites.

G A Puca, E Nola, U Hibner, G Cicala, V Sica.   

Abstract

The specific interaction between 17 beta-estradiol-receptor complex and nuclear acceptors was analyzed by immobilizing various nuclear proteins to CNBr-activated agarose. The specific, high affinity sites identified in a fraction of basic proteins that can be solubilized from purified nuclei of calf uterus (Puca, G.A., Sica, V., and Nola. E (1974) Proc. Natl. Acad. Sci. U.S.A. 71, 979-983) were chromatographed on Sephadex G-100 columns. Elution of the acceptor activity depends on the pH and ionic strength of the buffer used. With 5 mM HCl, however, a peak of acceptor activity with a molecular weight of about 70,000 was partially dissociated from the other basic nuclear proteins. The high affinity binding of the receptor to the acceptor proteins was estradiol-, but not progesterone-, cortisone-, or testosterone-dependent; it was very sensitive to ionic strength and showed a physiological pH optimum. Low affinity binding, such as that seen between receptor and histone, showed no estradiol dependence and little ionic strength and pH sensitivity. Native or heat-denatured DNA strongly modified the receptor-acceptor interaction, reducing the number of binding sites of acceptor for the receptor without changing the high affinity of the interaction. Heating of the acceptor protein before its covalent linkage to agarose considerably increased the affinity of the resulting agarose derivative. Free sulfhydryl groups of the receptor but not of the acceptor molecule play an important role in the acceptor-receptor interaction. When receptor and acceptor preparations were incubated in solution, the resulting complex was included on a Sephadex G-100 column and it eluted from DEAE-cellulose columns at lower ionic strength than the receptor alone. Even though not absolutely specific, these two properties allowed determination of the molecular weight (85,000) of the acceptor protein at neutral pH and more nearly physiological ionic strength. The apparent KD of the acceptor-receptor interaction was determined to be 2 x 10(-10) M at O degrees. Apparently similar, high affinity binding sites for estradiol receptors are also present in nuclei of other tissues.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169244

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Binding of estradiol receptor complexes to isolated human breast chromatin.

Authors:  E H Charreau; A Baldi
Journal:  Mol Cell Biochem       Date:  1977-07-05       Impact factor: 3.396

2.  Isolation of a chromatin fraction from calf endometrium highly enriched in estradiol binding sites.

Authors:  J M Sala-Trepat; U Hibner; C Vallet-Strouvé
Journal:  Nucleic Acids Res       Date:  1977-03       Impact factor: 16.971

3.  Interaction of two nonhistone proteins with the estradiol response element of the avian vitellogenin gene modulates the binding of estradiol-receptor complex.

Authors:  I M Feavers; J Jiricny; B Moncharmont; H P Saluz; J P Jost
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Assessment of estrogen receptor--histone interactions.

Authors:  J Kallos; T M Fasy; V P Hollander
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

5.  Nuclear acceptor sites for androgen-receptor complexes in seminal-vesicle epithelium.

Authors:  M J Weinberger; C M Veneziale
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

6.  Biological activities and receptor affinities of some natural and synthetic oestrogens and their D-homo analogues.

Authors:  W Lotz
Journal:  Experientia       Date:  1978-10-15

7.  Nuclear components responsible for the retention of steroid--receptor complexes, especially from the standpoint of the specifcity of hormonal responses.

Authors:  W I Mainwaring; E K Symes; S J Higgins
Journal:  Biochem J       Date:  1976-04-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.